Adaptimmune Therapeutics PLC (NAS:ADAP)
$ 0.7937 0 (0%) Market Cap: 202.99 Mil Enterprise Value: 35.54 Mil PE Ratio: 0 PB Ratio: 2.09 GF Score: 62/100

Adaptimmune Therapeutics PLC (ADAP) Transcripts

  • 1